Biomarkers · Inflammation
Lymphocyte-to-Monocyte Ratio (LMR)
Higher values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).
LMR and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to the curve's reference value, drawn from the published study (source below).
LMR by age and sex
Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.
The percentiles as a table
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 2.33 | 3.20 | 4.00 | 5.00 | 7.20 | 1,456 | NHANES 2017-2018 |
| All | 40-59 | 2.14 | 3.14 | 4.00 | 4.80 | 6.50 | 1,582 | NHANES 2017-2018 |
| All | 60+ | 1.75 | 2.50 | 3.25 | 4.20 | 6.00 | 1,939 | NHANES 2017-2018 |
| All | all | 2.00 | 3.00 | 3.80 | 4.75 | 6.67 | 4,977 | NHANES 2017-2018 |
| Men | 20-39 | 2.23 | 3.14 | 3.83 | 4.80 | 6.33 | 698 | NHANES 2017-2018 |
| Men | 40-59 | 1.97 | 3.00 | 3.60 | 4.40 | 5.75 | 740 | NHANES 2017-2018 |
| Men | 60+ | 1.71 | 2.38 | 3.00 | 3.78 | 5.50 | 981 | NHANES 2017-2018 |
| Men | all | 1.88 | 2.83 | 3.50 | 4.50 | 6.00 | 2,419 | NHANES 2017-2018 |
| Women | 20-39 | 2.50 | 3.40 | 4.20 | 5.33 | 7.75 | 758 | NHANES 2017-2018 |
| Women | 40-59 | 2.30 | 3.38 | 4.20 | 5.25 | 7.00 | 842 | NHANES 2017-2018 |
| Women | 60+ | 1.80 | 2.83 | 3.60 | 4.33 | 6.37 | 958 | NHANES 2017-2018 |
| Women | all | 2.17 | 3.17 | 4.00 | 5.00 | 7.00 | 2,558 | NHANES 2017-2018 |
Sources
- Risk curve: Hua 2023 (PMID 36905945): all-cause HR 1.26 (1.17-1.35) highest vs lowest MLR tertile (equivalent to lowest vs highest LMR tertile). Scaled to US values (NHANES).
- Hua et al. Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population. International journal of cardiology. 2023;379:118-126.
Map Lymphocyte-to-Monocyte Ratio (LMR) against another biomarker.
Related markers: Alpha-1-Antichymotrypsin (AACT) · Alpha-1-Antitrypsin (AAT) · Antinuclear Antibodies (ANA) · CD4:CD8 T-Cell Ratio · CD8+ T-Cell Count · Erythrocyte Sedimentation Rate (ESR) · Fibrinogen · Growth Differentiation Factor-15 (GDF-15)